Earnings Preview: CollPlant Biotechnologies
Portfolio Pulse from Benzinga Insights
CollPlant Biotechnologies (NASDAQ:CLGN) is set to release its latest quarterly earnings report on May 24, 2023. Analysts estimate an EPS of $-0.29. The company's past performance shows mixed results, with shares down 21.31% over the last 52-week period.

May 23, 2023 | 4:07 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
CollPlant Biotechnologies is set to release its quarterly earnings report on May 24, 2023, with an estimated EPS of $-0.29. The stock has experienced a 21.31% decline over the last 52 weeks.
The upcoming earnings report will provide insights into the company's financial performance. While the estimated EPS is negative, the actual impact on the stock price will depend on whether the company beats or misses the estimate and provides positive or negative guidance for the next quarter. The stock's past performance has been mixed, with a 21.31% decline over the last 52 weeks, which may concern long-term shareholders. However, the short-term impact is uncertain and depends on the earnings results and guidance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100